| RPG Life Sciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532983 |
NSE Symbol : RPGLIFE |
P/E(TTM) : 39.84 |
|
ISIN Demat : INE105J01010 |
Div & Yield% : 0.85 |
EPS(TTM) : 70.54 |
|
Book Value(₹) : 366.03 |
Market Cap(₹Cr) : 4,648.21 |
Face Value(₹) : 8.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 195.69 | 176.89 | 180.03 | 181.68 | 168.92 | 143.09 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 195.69 | 176.89 | 180.03 | 181.68 | 168.92 | 143.09 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.16 | 13.46 | 3.41 | 15.76 | 5.23 | 114.96 |
| Total Income | 199.85 | 190.35 | 183.44 | 197.44 | 174.15 | 258.05 |
| Total Expenditure | 152.11 | 144.02 | 148.69 | 142.65 | 133.45 | 117.60 |
| PBIDT | 47.74 | 46.33 | 34.75 | 54.79 | 40.70 | 140.45 |
| Interest | 0.63 | 0.39 | 0.25 | 0.12 | 0.13 | 0.18 |
| PBDT | 47.11 | 45.94 | 34.50 | 54.67 | 40.57 | 140.27 |
| Depreciation | 5.90 | 5.74 | 5.38 | 5.22 | 5.14 | 5.37 |
| Tax | 10.76 | 7.21 | 6.91 | 11.56 | 9.07 | 17.48 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.12 | 3.09 | 0.08 | 1.04 | 0.07 | 0.07 |
| Reported Profit After Tax | 30.57 | 29.90 | 22.13 | 36.85 | 26.29 | 117.35 |
| Extra-ordinary Items | 0.00 | 0.82 | -6.40 | 8.36 | 0.00 | 95.60 |
| Adjusted Profit After Extra-ordinary item | 30.57 | 29.08 | 28.53 | 28.49 | 26.29 | 21.75 |
| EPS (Unit Curr.) | 18.49 | 18.08 | 13.38 | 22.28 | 15.90 | 70.96 |
| EPS (Adj) (Unit Curr.) | 18.49 | 18.08 | 13.38 | 22.28 | 15.90 | 70.96 |
| Calculated EPS (Unit Curr.) | 18.49 | 18.08 | 13.38 | 22.28 | 15.90 | 70.96 |
| Calculated EPS (Adj) (Unit Curr.) | 18.49 | 18.08 | 13.38 | 22.28 | 15.90 | 70.96 |
| Calculated EPS (Ann.) (Unit Curr.) | 73.94 | 72.32 | 53.53 | 89.13 | 63.59 | 283.84 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 73.94 | 72.32 | 53.53 | 89.13 | 63.59 | 283.84 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.23 | 13.23 | 13.23 | 13.23 | 13.23 | 13.23 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 24.40 | 26.19 | 19.30 | 30.16 | 24.09 | 98.16 |
| PBDTM(%) | 24.07 | 25.97 | 19.16 | 30.09 | 24.02 | 98.03 |
| PATM(%) | 15.62 | 16.90 | 12.29 | 20.28 | 15.56 | 82.01 |
